Capital Raising Overview
Profit & Loss Statement
COVID-19 Impacted Results
Summary ($'m)
Revenue
H22
H21 Restated*
Change
217.6
213.2
4.4
300
259.1
EBITDA pre-significant items
(2.0)
9.7
(11.7)
EBITDA pre-significant items %
(0.9%)
4.5%
(5.4%)
200
100
Depreciation & Amortisation
(4.1)
(5.2)
1.1
EBIT pre-significant items
(6.1)
4.5
(10.6)
H20
Interest & Tax
0.5
(2.1)
2.6
(NLAT)/NPAT pre-significant items
(5.6)
2.4
(8.0)
(NLAT)/NPAT pre-significant items %
(2.6%)
1.1%
(3.7%)
16.0
11.7
(NLATA)/NPATA pre-significant items
(5.3)
2.7
(8.0)
12.0
(NLATA)/NPATA pre-significant items %
(2.4%)
1.3%
(3.7%)
8.0
4.0
Earnings per share pre-significant items (cps)
(1.29)
0.55
(1.84)
(4.0)
H20*
Significant Items**
(23.9)
(2.9)
(21.0)
Significant Items (net of tax)**
(16.7)
(2.0)
(14.7)
(NLAT)/NPAT (statutory)
(22.0)
0.4
(22.4)
(NLAT)/NPAT statutory (%)
(10.1%)
0.2%
(10.3%)
2.0
1.21
1.0
Earnings per share (cps)
(5.06)
0.09
(5.15)
* Amounts have been restated for the impact of the change in accounting interpretation around the capitalisation of software costs associated with
Software-as-a-Service ('SaaS').
** Primarily impacted by the settlement of the class action amounting to $20m.
Group Revenue
($'m)
213.2
217.6
H21
Group EBITDA pre-significant items
($'m)
9.7
H21*
EPS pre-significant items
(cents per share)
0.55
H22
(2.0)
H22
(1.29)
(1.0)
(2.0)
H20*
H21*
H22
Subject to rounding
14View entire presentation